As a follow-up to our 2018 survey covering patient perspectives on clinical research, SCORR and Antidote conducted a new survey this year to determine how opinions have changed. Part I of this report covered general survey findings and comparisons to 2018 data. In this second part, we dive deeper into the impact of demographics on these results.
Overall, Part I of our patient perspective survey revealed that more education is needed to ensure patients are informed about clinical research, and that this information is best received from professionals patients already know and trust. Messaging should include altruistic, benefit-based, and risk-aversion-related appeals, but the response to these appeals varies across demographics.
In this report, you’ll unlock insights into:
- How patient familiarity with and knowledge of clinical trials varies based on education level and household income
- The impact of education, household income, race/ethnicity, and age on where patients prefer to receive information
- How the previously mentioned demographics affect the factors that get patients invested in the research process
Get The Patient Perspective on Clinical Trials: Part I
Thank you to these Antidote Technologies partners for participating in the survey:
